SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 331 filers reported holding SAREPTA THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $932,422 | +1.7% | 8,142 | +15.1% | 0.01% | -11.1% |
| Q4 2022 | $916,779 | -26.5% | 7,075 | -55.7% | 0.01% | 0.0% |
| Q1 2022 | $1,247,000 | +0.3% | 15,958 | +15.6% | 0.01% | +12.5% |
| Q4 2021 | $1,243,000 | +88.9% | 13,802 | +94.1% | 0.01% | +60.0% |
| Q3 2021 | $658,000 | +200.5% | 7,112 | +151.9% | 0.01% | +150.0% |
| Q2 2021 | $219,000 | -71.6% | 2,823 | -72.7% | 0.00% | -71.4% |
| Q1 2021 | $770,000 | – | 10,337 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |